Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Merck KGaA Earnings Growth Beats Expectations
After-tax profit was 812 million euros compared with 740 million in the same period last year,
Merck
said Thursday. The
German
life-science and chemicals
company
attributed earnings growth to a recovery of its life-science segment, cost discipline and ...
Merck KGaA Q3 earnings rise faster than expected on lower costs
Merck KGaA on Thursday reported a gain of 11.9% in adjusted quarterly earnings, helped by cost-cutting measures and temporarily lower spending on drug research and development. The German pharma and technology company said in a statement that earnings before interest,
Merck KGaA (MKGAF) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Conference Call November 14, 2024 8:00 AM ETCompany ParticipantsConstantin Fest - Head of Investor
15h
Germany’s Merck Expects Sales at Lower End of Outlook Range After Third-Quarter Miss
The life-sciences and chemical group said it now expects 2024 net sales in the lower half of its previously expected range of ...
SHINE
5d
German companies express strong confidence in Chinese economy
German companies including Merck and ZEISS expressed strong confidence and high hopes for the Chinese market at the China ...
Business Wire
7d
Merck KGaA, Darmstadt, Germany and Intel Launch Academic Research Program in Europe for More Sustainable Semiconductor Manufacturing
DARMSTADT,
Germany
--(BUSINESS WIRE)--
Merck
KGaA, Darmstadt,
Germany
, a leading science and technology
company
, and Intel Corporation, one of the world’s largest semiconductor designers and ...
STAT
8h
Merck licenses Chinese cancer drug, searching for next Keytruda blockbuster
In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...
Yale Daily News
19h
Yale spin-off company Modifi Bio acquired by Merck in multimillion dollar deal
On Oct. 15, Modifi Bio, a Yale-based biotech
company
, closed an acquisition deal with
Merck
, an American pharmaceutical ...
BioPharma Dive
5h
Merck, facing threat to Keytruda, buys into new kind of cancer immunotherapy
The company is paying China-based biotech LaNova Medicines $588 million for the kind of dual-pronged antibody drug that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback